News
Sarepta’s treatment for Ebola, other viruses hit FDA fast track
Tue, 09/18/2012 - 12:00am
Sarepta Therapeutics Inc. (Nasdaq: SRPT) says it’s been granted fast-track status for two of its potential drugs to treat bioweapons, the Ebola virus and the Marburg virus, according to a statement.
